Accurate diagnosis of epilepsy is crucial in its management. Electroencephalogram (EEG) tests help to diagnose epilepsy and to establish the correct treatment. Interpreting the test requires specialists who are in short supply in under-resourced countries. To do our part in addressing this challenge, we are teaming up with TeleEEG (http://www.teleeeg.org), a registered charity in England and Wales.
TeleEEG establishes and supports epilepsy clinics in low-income countries to diagnose epilepsy and develop treatment plans. They have grown from a single clinic in Nepal in 2012 to 31 clinics in 16 countries. In the past 7 years, TeleEEG has diagnosed more than 10,000 cases. The average age of patients is 14.
For each clinic, TeleEEG provides an EEG machine and trains local healthcare professionals to do EEG tests. TeleEEG then analyzes test results through their team of 45 volunteer neurophysiologists. Where needed, ROW will grant an ongoing supply of Roweepra® (levetiracetam USP). Roweepra has proven successful in controlling seizures for some patients not helped by other available medication.
The ROW Foundation and TeleEEG partnership will make a life-changing difference for tens of thousands currently without access to proper diagnosis and effective treatment.